rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Healthpeak Properties, Inc.

DOC · NYSE

Real EstateREITsSetting up

DOC stood above a rising 150-day average in 18 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 3.4% below that average now. REITs: 11% of its 170 stocks in an uptrend (−10 points in four weeks); Real Estate: 11% (−11 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 3
Industry in uptrend
11% -10 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$427K
Officials’ trades on record
12

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.

17 Apr – 16 Oct
12%33%54%Apr 26Jun 26Jul 26Sep 26Oct 26

REITs: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Real Estate: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$386K$0$678KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

12 disclosed lines: House 10, Senate 1, executive 1; 7 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k10 Apr 2026filed 1 Jul 2026
Alan Armstrong Senate: U.S. Senate eFDSenatorbought$1k–$15k27 Mar 2026filed 21 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k10 Feb 2026filed 9 Mar 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k9 Jan 2026filed 13 Feb 2026
Lisa C. McClain House: U.S. House ClerkMI09soldspouse$1k–$15k4 Aug 2025filed 12 Sep 2025
Lisa C. McClain House: U.S. House ClerkMI09boughtspouse$1k–$15k17 Jun 2025filed 13 Aug 2025
Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08sold$1k–$15k15 May 2025filed 9 Jun 2025
Julie Johnson House: U.S. House ClerkTX32soldjoint$1k–$15k1 Apr 2025filed 14 May 2025
Chris Jacobs House: U.S. House ClerkNY27bought$1k–$15k12 Dec 2022filed 20 Jan 2023
Chris Jacobs House: U.S. House ClerkNY27sold$1k–$15k8 Nov 2022filed 12 Dec 2022
Chris Jacobs House: U.S. House ClerkNY27sold$1k–$15k18 Jul 2022filed 9 Sep 2022
Chris Jacobs House: U.S. House ClerkNY27bought$15k–$50k21 Jun 2022filed 28 Jul 2022

Insiders

Buy orders, 12 months0
Sale orders, 12 months1
Buyers · sellers0 · 1
WhoDidSharesTraded
Scott R. BohnCDO and Head of Labsold10,989at $19.4512 May 2026filed 13 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Adam G. Mabry Company insiderCIO · last 29 May 20260 · 0
Ankit B. Patadia Company insiderEVP and Treasurer · last 29 May 20260 · 0
John T. Thomas Company insiderDirector · last 29 May 20262 · 0
Kelvin O. Moses Company insiderChief Financial Officer · last 29 May 20260 · 0
Scott M. Brinker Company insiderPresident and CEO · last 29 May 20266 · 0
Shawn G. Johnston Company insiderEVP and CAO · last 29 May 20260 · 0
Scott R. Bohn Company insiderCDO and Head of Lab · last 12 May 20260 · 1
Ava Lias-Booker Company insiderDirector · last 6 May 20261 · 0
Brian G. Cartwright Company insiderDirector · last 6 May 20260 · 0
James B. Connor Company insiderDirector · last 6 May 20260 · 0
Katherine M. Sandstrom Company insiderDirector · last 6 May 20261 · 0
R. Kent Griffin Jr. Company insiderDirector · last 6 May 20261 · 0

Same industry

CXW CoreCivicLeading+12%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2024 · to 31 Dec 202460.2%
Free cash flow marginFY 2025 · to 31 Dec 202512.6%
Cash conversionFY 2024 · to 31 Dec 2024440%
Debt to equityFY 2025 · to 31 Dec 20251.31×
Share count trendFY 2025 · to 30 Jan 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$467.5M
Free cash flowFY 2025 · to 31 Dec 2025$357.0M

Analyst forecasts

No analyst forecasts yet.